Jump to: Authorized Access | Attribution | Authorized Requests

Study Description

Lung carcinoma is the leading cause of cancer death in the United States and world-wide; lung adenocarcinoma is the most common cause of lung cancer. Pilot studies of lung adenocarcinoma with hybrid-capture based whole exome sequencing will enable us to identify new targets for therapy and improve diagnosis. We will analyze a blend of whole exome and whole genome sequencing data as well as copy number and somatic mutation calls for 200 tumor and matched normal controls. When completed this study will represent the most comprehensive lung adenocarcinoma genome dataset to date.

  • Study Design:
    • Case Set
  • Study Type:
    • Case Set
Authorized Access
Publicly Available Data (Public ftp)
Study Inclusion/Exclusion Criteria


Molecular Data
TypeSourcePlatformNumber of Oligos/SNPsSNP Batch IdComment
Whole Exome Sequencing Agilent Agilent selected, 76bp paired end reads N/A N/A
Whole Genome Sequencing Illumina 101bp paired end reads N/A N/A
Whole Genome Genotyping Affymetrix AFFY_6.0 934940 52074
Selected publications
Diseases/Traits Related to Study (MeSH terms)
Links to Related Resources
Authorized Data Access Requests
Study Attribution